Overview

This trial is active, not recruiting.

Condition amphetamine-related disorders
Phase phase 4
Sponsor National Institute on Drug Abuse (NIDA)
Trial size 43 participants
Trial identifier NCT00000351, NIDA-3-0010-16

Summary

Part II: Examine cognitive performance of stimulant abusers (methamphetamine and cocaine) during recovery by assessing their cognitive function at monthly intervals.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective cross-sectional

Eligibility Criteria

Male or female participants of any age.

Please contact site for information Inclusion Criteria: M/F. Meet DSM-IV criteria for stimulant dependence. Agree to conditions of the study and sign informed consent.

Additional Information

Official title Cognitive Correlates of Substance Abuse, Part 2
Principal investigator Walter Ling, M.D.
Description Part II: Examine cognitive performance of stimulant abusers (methamphetamine and cocaine) during recovery by assessing their cognitive function at monthly intervals.
Trial information was received from ClinicalTrials.gov and was last updated in June 2005.
Information provided to ClinicalTrials.gov by National Institute on Drug Abuse (NIDA).